Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sanders

Showing results (701-710 of 915) with videos related to

Pageof 92
Sort By:
Cell Host & Microbe|June 14, 2019
Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing AntibodiesMeng Yuan, Christopher A Cottrell, Gabriel Ozorowski, et al.
AIDS Research and Human Retroviruses|February 25, 2016
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting SubtypeMarion Cornelissen, Zelda Euler, Tom L G M van den Kerkhof, et al.
Cell Reports|October 7, 2020
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding DomainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformationRajesh P Ringe, Rogier W Sanders, Anila Yasmeen, et al.
Nature Immunology|August 4, 2009
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduitsWeifeng Xu, Paul A Santini, John S Sullivan, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2013
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9Jean-Philippe Julien, Jeong Hyun Lee, Albert Cupo, et al.
The American Journal of Tropical Medicine and Hygiene|April 8, 2015
Needs, acceptability, and value of humanitarian medical assistance in remote Peruvian Amazon riverine communitiesJuan F Sanchez, Eric S Halsey, Angela M Bayer, et al.
Plos Pathogens|March 7, 2022
Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patternsIlhan Tomris, Kim M Bouwman, Youri Adolfs, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Pageof 92

Showing results (701-710 of 915) with videos related to

Sort By:
Pageof 92
Cell Host & Microbe|June 14, 2019
Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing AntibodiesMeng Yuan, Christopher A Cottrell, Gabriel Ozorowski, et al.
AIDS Research and Human Retroviruses|February 25, 2016
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting SubtypeMarion Cornelissen, Zelda Euler, Tom L G M van den Kerkhof, et al.
Cell Reports|October 7, 2020
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding DomainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformationRajesh P Ringe, Rogier W Sanders, Anila Yasmeen, et al.
Nature Immunology|August 4, 2009
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduitsWeifeng Xu, Paul A Santini, John S Sullivan, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domainNicholas C Wu, Meng Yuan, Hejun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2013
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9Jean-Philippe Julien, Jeong Hyun Lee, Albert Cupo, et al.
The American Journal of Tropical Medicine and Hygiene|April 8, 2015
Needs, acceptability, and value of humanitarian medical assistance in remote Peruvian Amazon riverine communitiesJuan F Sanchez, Eric S Halsey, Angela M Bayer, et al.
Plos Pathogens|March 7, 2022
Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patternsIlhan Tomris, Kim M Bouwman, Youri Adolfs, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Pageof 92